ACTIV 4a - A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitals Adults with COVID-19

Administered By

Awarded By

Contributors

Start/End

  • December 11, 2020 - May 31, 2022